Search Results - Sierra Li

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Regorafenib, Ipilimumab, and Nivolumab for Patients With Microsatellite Stable Colorectal Cancer and Disease Progression With Prior Chemotherapy

    Regorafenib, Ipilimumab, and Nivolumab for Patients With Microsatellite Stable Colorectal Cancer and Disease Progression With Prior Chemotherapy by Marwan Fakih, Jaideep Sandhu, Dean Lim, Xiaochen Li, Sierra Li, Chongkai Wang

    Published 2023
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Rhabdoid Tumor of the Kidney in The National Wilms' Tumor Study: Age at Diagnosis As a Prognostic Factor

    Rhabdoid Tumor of the Kidney in The National Wilms' Tumor Study: Age at Diagnosis As a Prognostic Factor by Gail E. Tomlinson, Norman E. Breslow, Jeffrey S. Dome, Katherine A. Guthrie, Pat Norkool, Sierra Li, Patrick R. Thomas, Elizabeth J. Perlman, J. Bruce Beckwith, Giulio J. D’Angio, Daniel M. Green

    Published 2005
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Effect of Duration of Treatment on Treatment Outcome for Patients With Clear-Cell Sarcoma of the Kidney: A Report From the National Wilms' Tumor Study Group

    Effect of Duration of Treatment on Treatment Outcome for Patients With Clear-Cell Sarcoma of the Kidney: A Report From the National Wilms' Tumor Study Group by Nita L. Seibel, Sierra Li, Norman E. Breslow, J. Bruce Beckwith, Daniel M. Green, Gerald M. Haase, Michael L. Ritchey, Patrick R. Thomas, Paul E. Grundy, Jerry Z. Finklestein, Tae Il Kim, Stephen J. Shochat, Panayotis P. Kelalis, Giulio J. D’Angio

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer

    De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer by Xiwei Wu, George Somlo, Yang Yu, Melanie R. Palomares, Arthur Xuejun Li, Weiying Zhou, Amy Chow, Yun Yen, John J. Rossi, Harry Gao, Jinhui Wang, Yate‐Ching Yuan, Paul Frankel, Sierra Li, Kimlin T. Ashing‐Giwa, Guihua Sun, Yafan Wang, R. Jeffrey Smith, Kim S. Robinson, Xiubao Ren, Shizhen Emily Wang

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Loss of Heterozygosity for Chromosomes 1p and 16q Is an Adverse Prognostic Factor in Favorable-Histology Wilms Tumor: A Report From the National Wilms Tumor Study Group

    Loss of Heterozygosity for Chromosomes 1p and 16q Is an Adverse Prognostic Factor in Favorable-Histology Wilms Tumor: A Report From the National Wilms Tumor Study Group by Paul E. Grundy, Norman E. Breslow, Sierra Li, Elizabeth J. Perlman, J. Bruce Beckwith, Michael L. Ritchey, Robert C. Shamberger, Gerald M. Haase, Giulio J. D’Angio, Milton H. Donaldson, Max J. Coppes, Marcio H. Malogolowkin, Patricia Shearer, Patrick R. Thomas, Roger M. Macklis, Gail E. Tomlinson, Vicki Huff, Daniel M. Green

    Published 2005
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: